NO953883L - Rensing av faktor VII - Google Patents

Rensing av faktor VII

Info

Publication number
NO953883L
NO953883L NO953883A NO953883A NO953883L NO 953883 L NO953883 L NO 953883L NO 953883 A NO953883 A NO 953883A NO 953883 A NO953883 A NO 953883A NO 953883 L NO953883 L NO 953883L
Authority
NO
Norway
Prior art keywords
purification
factor vii
purification steps
fvi1
degradation
Prior art date
Application number
NO953883A
Other languages
English (en)
Norwegian (no)
Other versions
NO953883D0 (no
Inventor
Tony Joergensen
Anders H Pedersen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO953883D0 publication Critical patent/NO953883D0/no
Publication of NO953883L publication Critical patent/NO953883L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6437—Coagulation factor VIIa (3.4.21.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21021—Coagulation factor VIIa (3.4.21.21)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Catalysts (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
NO953883A 1993-03-31 1995-09-29 Rensing av faktor VII NO953883L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK93382A DK38293D0 (da) 1993-03-31 1993-03-31 Fremstilling af proteiner
PCT/DK1994/000122 WO1994022905A1 (en) 1993-03-31 1994-03-24 Purification of factor vii

Publications (2)

Publication Number Publication Date
NO953883D0 NO953883D0 (no) 1995-09-29
NO953883L true NO953883L (no) 1995-11-28

Family

ID=8092871

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953883A NO953883L (no) 1993-03-31 1995-09-29 Rensing av faktor VII

Country Status (16)

Country Link
US (1) US5700914A (en:Method)
EP (1) EP0691984A1 (en:Method)
JP (1) JPH08508264A (en:Method)
CN (1) CN1039231C (en:Method)
AU (1) AU677309B2 (en:Method)
CA (1) CA2159313A1 (en:Method)
CZ (1) CZ253395A3 (en:Method)
DK (1) DK38293D0 (en:Method)
FI (1) FI954649A0 (en:Method)
HU (1) HUT72712A (en:Method)
IL (1) IL109164A0 (en:Method)
NO (1) NO953883L (en:Method)
PL (1) PL310887A1 (en:Method)
TW (1) TW278079B (en:Method)
WO (1) WO1994022905A1 (en:Method)
ZA (1) ZA941956B (en:Method)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19538716A1 (de) * 1995-10-18 1997-04-24 Behringwerke Ag Verfahren zur Quantifizierung von aktiviertem Gerinnungsfaktor VII (FVIIa)
DE19538715A1 (de) * 1995-10-18 1997-04-30 Behringwerke Ag Verfahren zur Reinigung von Faktor VII und aktiviertem Faktor VII
CN103641885A (zh) † 1998-05-06 2014-03-19 基因技术股份有限公司 用离子交换层析纯化蛋白质
AT408613B (de) * 1998-06-17 2002-01-25 Immuno Ag Pharmazeutisches faktor vii-präparat
ATE428445T1 (de) 2000-02-11 2009-05-15 Bayer Healthcare Llc Gerinnungsfaktor vii oder viia konjugate
PL370652A1 (en) * 2001-12-21 2005-05-30 Novo Nordisk Health Care Ag Liquid composition of factor vii polypeptides
US20040009918A1 (en) * 2002-05-03 2004-01-15 Hanne Nedergaard Stabilised solid compositions of modified factor VII
CN1671410B (zh) * 2002-06-21 2010-05-12 诺和诺德医疗保健公司 因子ⅶ多肽的稳定化固体组合物
CN1780637A (zh) * 2003-03-18 2006-05-31 诺和诺德医疗保健公司 因子ⅶ多肽类的含水液体药物组合物
US7897734B2 (en) 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
BRPI0409936A (pt) * 2003-05-23 2006-04-25 Novo Nordisk Healthcare Ag uso de um material, recipiente pelo menos parcialmente cheio, e, kit médico
WO2004112828A1 (en) * 2003-06-25 2004-12-29 Novo Nordisk Health Care Ag Liquid composition of factor vii polypeptides
JP5306597B2 (ja) * 2003-07-01 2013-10-02 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 第ｖｉｉ因子ポリペプチドの液体水性薬学的組成物
MXPA06001698A (es) 2003-08-14 2006-05-19 Novo Nordisk Healthcare Ag Composicion farmaceutica liquida y acuosa de polipetidos de factor vii.
CN102351953B (zh) 2003-12-01 2017-05-10 诺和诺德医疗保健公司 液体因子vii组合物的病毒过滤
DK2298287T3 (en) * 2003-12-19 2018-07-23 Novo Nordisk Healthcare Ag Stabilized compositions of factor VII polypeptides
WO2006067230A1 (en) * 2004-12-23 2006-06-29 Novo Nordisk Health Care Ag Reduction of the content of protein contaminants in compositions comprising a vitamin k-dependent protein of interest
US20090047723A1 (en) * 2005-01-14 2009-02-19 Bayer Healthcare Llc Method for purification of factor vii
PT1907540E (pt) * 2005-07-22 2013-02-04 Bayer Healthcare Llc Activação do factor vii em solução
US8841255B2 (en) 2005-12-20 2014-09-23 Duke University Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
WO2007073486A2 (en) * 2005-12-20 2007-06-28 Duke University Methods and compositions for delivering active agents with enhanced pharmacological properties
US20130172274A1 (en) 2005-12-20 2013-07-04 Duke University Methods and compositions for delivering active agents with enhanced pharmacological properties
EP4074327A1 (en) 2008-06-27 2022-10-19 Duke University Therapeutic agents comprising elastin-like peptides
CN103539852B (zh) * 2012-07-12 2015-08-12 上海泰龙生物医药科技有限公司 一种从细胞培养液中分离纯化重组人凝血八因子的方法
EP2687595B1 (en) 2012-07-19 2018-05-30 Laboratoire Français du Fractionnement et des Biotechnologies Method for purifying transgenic factor VII
CA2888199C (en) 2012-10-17 2019-06-25 The Procter & Gamble Company Strip for the delivery of an oral care active and methods for applying oral care actives
US11059857B2 (en) 2016-12-22 2021-07-13 Km Biologics Co., Ltd. Chromatographic method for collecting blood coagulation factor VII with high yield

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981952A (en) * 1988-10-04 1991-01-01 Eli Lilly And Company Method for the purification of vitamin K-dependent proteins

Also Published As

Publication number Publication date
CN1039231C (zh) 1998-07-22
FI954649A7 (fi) 1995-09-29
FI954649L (fi) 1995-09-29
FI954649A0 (fi) 1995-09-29
ZA941956B (en) 1994-09-30
WO1994022905A1 (en) 1994-10-13
HU9502846D0 (en) 1995-12-28
DK38293D0 (da) 1993-03-31
HUT72712A (en) 1996-05-28
US5700914A (en) 1997-12-23
PL310887A1 (en) 1996-01-08
CA2159313A1 (en) 1994-10-13
IL109164A0 (en) 1994-06-24
TW278079B (en:Method) 1996-06-11
JPH08508264A (ja) 1996-09-03
EP0691984A1 (en) 1996-01-17
AU677309B2 (en) 1997-04-17
CZ253395A3 (en) 1996-01-17
AU6423994A (en) 1994-10-24
NO953883D0 (no) 1995-09-29
CN1121723A (zh) 1996-05-01

Similar Documents

Publication Publication Date Title
NO953883L (no) Rensing av faktor VII
GB2270030B (en) Method of producing fibre or film
DE69426278D1 (de) Kontinuierliche Herstellung eines Schlammes mit mehreren Komponenten
PL310550A1 (en) Fibre treating method
AU6430794A (en) A method of treating endo-osteal materials
ZA945657B (en) Method to inhibit restenosis
FI944443A0 (fi) Menetelmä kaasun syöttämiseksi nesteeseen
DE69433831D1 (de) Modifizierung von Pertussistoxin
FI961431L (fi) Prosessi II
DE69329844D1 (de) Beschichtungsverfahren
DE69318527D1 (de) Entwicklungsverfahren
DE69406974D1 (de) Beschichtungsverfahren
HUT69949A (en) Novel plant promoter
DE69417190D1 (de) Beschichtungsverfahren
AU7687891A (en) Method for treating mechanical pulp plant effluent
AU5682790A (en) Method of treating tinea
NO810367L (no) Midler og prosess for beskyttelse av tre og belegg mot mikroorganismer.
FR2708210B1 (fr) Procédé de traitement d'un milieu poreux obstrué.
FI933530L (fi) Anordning foer tvinning av tvinningselement i vaexlande riktning
TW288066B (en:Method)
AU7318691A (en) A method of treating a mammal with a biologically active compound
DE69408925D1 (de) Beschichtungsverfahren
FI945440L (fi) Prosessilaitos
FR2687403B1 (fr) Procede de fabrication d'un ester d'un compose organosilane et utilisation.
DK0587480T3 (da) Deponeringsindretning